Ana Piñar-Gutiérrez , Miguel Ángel Mangas-Cruz , Irene de Lara-Rodríguez , Pablo Remón-Ruiz , Diego del Can-Sánchez , María Tous Castillo , Alfonso Pumar-López
{"title":"新型 ARMC 5 基因突变导致的家族性双侧大结节性肾上腺增生症:临床状况及与其他肿瘤的可能关联","authors":"Ana Piñar-Gutiérrez , Miguel Ángel Mangas-Cruz , Irene de Lara-Rodríguez , Pablo Remón-Ruiz , Diego del Can-Sánchez , María Tous Castillo , Alfonso Pumar-López","doi":"10.1016/j.endien.2024.03.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction/Objectives</h3><p>Mutations in the <em>ARMC5</em> (armadillo repeat containing 5, OMIM <span>615549</span><svg><path></path></svg>) gene, a putative tumor suppressor gene, have recently been identified as a common cause of sporadic and familial bilateral macronodular adrenal hyperplasia (BMAH). Familial BMAH is thought to be caused by two mutations, one germline and the other somatic, as suggested by the 2-hit theory. The objective is to describe a new mutation and develop its clinical characteristics and implications.</p></div><div><h3>Methods, Results and Conclusions</h3><p>We present an affected family with 11 members carrying a novel mutation of the <em>ARMC5</em> gene (NM_001288767.1): c.2162T>C p. (Leu721Pro). Two of the carriers developed clinical Cushing's syndrome (CS), two mild autonomous cortisol secretion (MACS) and one presented with autonomous cortisol secretion (ACS). Four patients developed other tumors, three of whom died from this cause. It is not known whether these tumors could be related to the described mutation.</p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"71 3","pages":"Pages 119-123"},"PeriodicalIF":1.8000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Familial bilateral macronodular adrenal hyperplasia due to a novel ARMC 5 germline mutation: Clinical status and possible association with other neoplasms\",\"authors\":\"Ana Piñar-Gutiérrez , Miguel Ángel Mangas-Cruz , Irene de Lara-Rodríguez , Pablo Remón-Ruiz , Diego del Can-Sánchez , María Tous Castillo , Alfonso Pumar-López\",\"doi\":\"10.1016/j.endien.2024.03.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction/Objectives</h3><p>Mutations in the <em>ARMC5</em> (armadillo repeat containing 5, OMIM <span>615549</span><svg><path></path></svg>) gene, a putative tumor suppressor gene, have recently been identified as a common cause of sporadic and familial bilateral macronodular adrenal hyperplasia (BMAH). Familial BMAH is thought to be caused by two mutations, one germline and the other somatic, as suggested by the 2-hit theory. The objective is to describe a new mutation and develop its clinical characteristics and implications.</p></div><div><h3>Methods, Results and Conclusions</h3><p>We present an affected family with 11 members carrying a novel mutation of the <em>ARMC5</em> gene (NM_001288767.1): c.2162T>C p. (Leu721Pro). Two of the carriers developed clinical Cushing's syndrome (CS), two mild autonomous cortisol secretion (MACS) and one presented with autonomous cortisol secretion (ACS). Four patients developed other tumors, three of whom died from this cause. It is not known whether these tumors could be related to the described mutation.</p></div>\",\"PeriodicalId\":48650,\"journal\":{\"name\":\"Endocrinologia Diabetes Y Nutricion\",\"volume\":\"71 3\",\"pages\":\"Pages 119-123\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrinologia Diabetes Y Nutricion\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2530018024000337\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinologia Diabetes Y Nutricion","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2530018024000337","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
导言/目的最近发现,ARMC5(含犰狳重复5,OMIM 615549)基因突变是散发性和家族性双侧巨肾上腺皮质增生症(BMAH)的常见病因,该基因是一种推定的肿瘤抑制基因。家族性肾上腺增生症被认为是由两个突变引起的,一个是种系突变,另一个是体细胞突变。我们介绍了一个受影响的家族,该家族有 11 名成员携带 ARMC5 基因(NM_001288767.1)的新型突变:c.2162T>C p. (Leu721Pro)。其中两名携带者出现临床库欣综合征(CS),两名出现轻度自主皮质醇分泌(MACS),一名出现自主皮质醇分泌(ACS)。四名患者出现了其他肿瘤,其中三人因此死亡。目前尚不清楚这些肿瘤是否与所述突变有关。
Familial bilateral macronodular adrenal hyperplasia due to a novel ARMC 5 germline mutation: Clinical status and possible association with other neoplasms
Introduction/Objectives
Mutations in the ARMC5 (armadillo repeat containing 5, OMIM 615549) gene, a putative tumor suppressor gene, have recently been identified as a common cause of sporadic and familial bilateral macronodular adrenal hyperplasia (BMAH). Familial BMAH is thought to be caused by two mutations, one germline and the other somatic, as suggested by the 2-hit theory. The objective is to describe a new mutation and develop its clinical characteristics and implications.
Methods, Results and Conclusions
We present an affected family with 11 members carrying a novel mutation of the ARMC5 gene (NM_001288767.1): c.2162T>C p. (Leu721Pro). Two of the carriers developed clinical Cushing's syndrome (CS), two mild autonomous cortisol secretion (MACS) and one presented with autonomous cortisol secretion (ACS). Four patients developed other tumors, three of whom died from this cause. It is not known whether these tumors could be related to the described mutation.
期刊介绍:
Endocrinología, Diabetes y Nutrición is the official journal of the Spanish Society of Endocrinology and Nutrition (Sociedad Española de Endocrinología y Nutrición, SEEN) and the Spanish Society of Diabetes (Sociedad Española de Diabetes, SED), and was founded in 1954.
The aim of the journal is to improve knowledge and be a useful tool in practice for clinical and laboratory specialists, trainee physicians, researchers, and nurses interested in endocrinology, diabetes, nutrition and related disciplines.
It is an international journal published in Spanish (print and online) and English (online), covering different fields of endocrinology and metabolism, including diabetes, obesity, and nutrition disorders, as well as the most relevant research produced mainly in Spanish language territories.
The quality of the contents is ensured by a prestigious national and international board, and by a selected panel of specialists involved in a rigorous peer review. The result is that only manuscripts containing high quality research and with utmost interest for clinicians and professionals related in the field are published.
The Journal publishes Original clinical and research articles, Reviews, Special articles, Clinical Guidelines, Position Statements from both societies and Letters to the editor.
Endocrinología, Diabetes y Nutrición can be found at Science Citation Index Expanded, Medline/PubMed and SCOPUS.